title: Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.
abstract: To evaluate concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue after intravenous administration, patients greater than or equal to 16 years old diagnosed with acute cholecystitis were randomly assigned to receive ofloxacin (400 mg) intravenously every 12 h or ceftazidime (2 g) intravenously every 8 h. Doses of each regimen were given preoperatively. Serum, bile fluid, and gallbladder wall tissue samples of consecutive patients in the ofloxacin group were obtained intraoperatively. The samples were frozen at -70 degrees C until analyzed by high-pressure liquid chromatography. Twenty-three patients (6 males and 17 females) were evaluated. The mean (+/- the standard deviation) ofloxacin concentrations in serum, bile fluid, and gallbladder wall tissue were 2.9 +/- 2.4 and 6.0 +/- 7.9 micrograms/ml and 3.1 +/- 2.9 micrograms/g, respectively. The mean number of doses each patient received before surgery was 5.3 +/- 3.0, and the mean delta time (time elapsed between last antibiotic administration and when intraoperative samples were obtained) was 9.6 +/- 7.5 h. The mean tissue-to-serum ratio was 1.2 +/- 0.5, and the mean bile-to-serum ratio was 2.3 +/- 1.4. The mean serum ofloxacin concentrations were not statistically different from the concentrations in bile (P = 0.1) and tissue (P = 0.7) at the mean delta time. The study revealed that concentrations of ofloxacin in serum, bile fluid, and gallbladder tissue after intravenous dosing were adequate against susceptible organisms found in the biliary tract.
authors.affiliation: School of Pharmacy, University of Southern California, Los Angeles 90033.
authors.forename: A
authors.initials: A
authors.lastname: Chin
authors.forename: M P
authors.initials: MP
authors.lastname: Okamoto
authors.forename: M A
authors.initials: MA
authors.lastname: Gill
authors.forename: D A
authors.initials: DA
authors.lastname: Sclar
authors.forename: T V
authors.initials: TV
authors.lastname: Berne
authors.forename: A E
authors.initials: AE
authors.lastname: Yellin
authors.forename: P N
authors.initials: PN
authors.lastname: Heseltine
authors.forename: M D
authors.initials: MD
authors.lastname: Appleman
mesh_terms: D000328:Adult; D001646:Bile / Q000378:metabolism*; D005260:Female; D005704:Gallbladder / Q000378:metabolism*; D006801:Humans; D007275:Injections, Intravenous; D007432:Intraoperative Period; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D012044:Regression Analysis
chemical_list: D015242:Ofloxacin